UK and US governments pursue contrasting vaccine strategies
While the UK’s Vaccine Innovation Pathway succeeds, the vaccine future in the US is destabilising.

While the UK’s Vaccine Innovation Pathway succeeds, the vaccine future in the US is destabilising.
Lisata will utilise GATC's Multiomics Advanced Technology platform.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Juvenescence enhances AI drug discovery with Ro5 acquisition
Pharma’s AI prospects get nudged into the future with EU’s AI actÂ
Next-generation targeting for evolving HCP engagement
Are regulators keeping pace with AI adoption in clinical trials?